Koninklijke Philips Net Profit Margin 2012-2025 | PHG
Current and historical net profit margin for Koninklijke Philips (PHG) from 2012 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Koninklijke Philips net profit margin for the three months ending December 31, 2025 was .
| Koninklijke Philips Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-12-31 | $20.18B | $1.01B | 5.02% |
| 2025-09-30 | $19.08B | $0.77B | 4.01% |
| 2025-06-30 | $18.86B | $1.04B | 5.50% |
| 2025-03-31 | $18.81B | $0.84B | 4.49% |
| 2024-09-30 | $18.97B | $0.05B | 0.26% |
| 2024-06-30 | $18.60B | $-0.17B | -0.92% |
| 2023-06-30 | $18.89B | $-0.48B | -2.53% |
| 2023-03-31 | $18.85B | $-0.33B | -1.73% |
| 2022-06-30 | $19.63B | $0.66B | 3.36% |
| 2021-06-30 | $20.30B | $0.68B | 3.37% |
| 2020-06-30 | $19.93B | $0.78B | 3.90% |
| 2019-06-30 | $22.93B | $1.23B | 5.36% |
| 2018-06-30 | $24.26B | $1.37B | 5.64% |
| 2017-06-30 | $25.77B | $1.84B | 7.15% |
| 2016-12-31 | $27.13B | $1.60B | 5.91% |
| 2016-09-30 | $27.08B | $0.87B | 3.22% |
| 2016-06-30 | $26.99B | $0.81B | 3.02% |
| 2016-03-31 | $26.98B | $0.64B | 2.37% |
| 2015-12-31 | $26.92B | $0.72B | 2.66% |
| 2015-09-30 | $26.06B | $0.94B | 3.60% |
| 2015-06-30 | $26.93B | $0.44B | 1.65% |
| 2015-03-31 | $27.58B | $0.48B | 1.72% |
| 2014-12-31 | $28.44B | $0.55B | 1.94% |
| 2014-09-30 | $30.72B | $0.94B | 3.05% |
| 2014-06-30 | $30.80B | $1.45B | 4.70% |
| 2014-03-31 | $30.92B | $1.53B | 4.95% |
| 2013-12-31 | $30.99B | $1.55B | 5.01% |
| 2013-09-30 | $31.41B | $0.52B | 1.65% |
| 2013-06-30 | $31.96B | $0.37B | 1.15% |
| 2013-03-31 | $31.77B | $0.16B | 0.49% |
| 2012-12-31 | $32.19B | $0.27B | 0.84% |
| 2012-09-30 | $31.35B | $0.54B | 1.72% |
| 2012-06-30 | $30.80B | $0.42B | 1.36% |
| 2012-03-31 | $31.11B | $-1.72B | -5.52% |
| 2011-12-31 | $31.33B | $-1.85B | -5.89% |
| 2011-09-30 | $32.59B | $-1.00B | -3.08% |
| 2011-06-30 | $33.09B | $-0.43B | -1.30% |
| 2011-03-31 | $33.49B | $1.84B | 5.48% |
| 2010-12-31 | $33.77B | $1.91B | 5.67% |
| 2010-09-30 | $34.44B | $1.67B | 4.84% |
| 2010-06-30 | $34.60B | $1.25B | 3.60% |
| 2010-03-31 | $34.14B | $0.98B | 2.87% |
| 2009-12-31 | $32.91B | $0.63B | 1.90% |
| 2009-09-30 | $32.42B | $-2.02B | -6.24% |
| 2009-06-30 | $33.85B | $-1.74B | -5.13% |
| 2009-03-31 | $36.52B | $-0.68B | -1.85% |
| 2008-12-31 | $38.81B | $-0.27B | -0.71% |
| 2008-09-30 | $40.05B | $3.90B | 9.74% |
| 2008-06-30 | $39.47B | $3.82B | 9.67% |
| 2008-03-31 | $37.59B | $4.81B | 12.79% |
| 2007-12-31 | $36.50B | $5.63B | 15.41% |
| 2007-09-30 | $35.52B | $4.44B | 12.50% |
| 2007-06-30 | $34.61B | $9.40B | 27.16% |
| 2007-03-31 | $35.94B | $7.66B | 21.32% |
| 2006-12-31 | $36.96B | $6.71B | 18.15% |
| 2006-09-30 | $37.80B | $6.38B | 16.87% |
| 2006-06-30 | $39.05B | $2.94B | 7.52% |
| 2006-03-31 | $39.12B | $4.37B | 11.17% |
| 2005-12-31 | $38.95B | $4.33B | 11.12% |
| 2005-09-30 | $44.75B | $4.87B | 10.88% |
| 2005-06-30 | $44.29B | $4.33B | 9.77% |
| 2005-03-31 | $43.45B | $3.26B | 7.50% |
| 2004-12-31 | $43.03B | $3.79B | 8.81% |
| 2004-09-30 | $36.64B | $3.58B | 9.76% |
| 2004-06-30 | $35.68B | $2.28B | 6.40% |
| 2004-03-31 | $34.33B | $1.59B | 4.62% |
| 2003-12-31 | $33.02B | $0.83B | 2.50% |
| 2003-09-30 | $31.21B | $-1.42B | -4.54% |
| 2003-06-30 | $30.53B | $-1.88B | -6.17% |
| 2003-03-31 | $30.46B | $-3.18B | -10.44% |
| 2002-12-31 | $30.11B | $-3.09B | -10.27% |
| 2002-09-30 | $29.48B | $-2.58B | -8.76% |
| 2002-06-30 | $28.64B | $-2.97B | -10.35% |
| 2002-03-31 | $27.92B | $-2.38B | -8.53% |
| 2001-12-31 | $28.84B | $-2.30B | -7.96% |
| 2001-09-30 | $30.28B | $1.20B | 3.95% |
| 2001-06-30 | $32.42B | $3.78B | 11.65% |
| 2001-03-31 | $34.35B | $7.81B | 22.75% |
| 2000-12-31 | $35.03B | $8.84B | 25.24% |
| 2000-09-30 | $35.19B | $7.08B | 20.12% |
| 2000-06-30 | $34.86B | $5.60B | 16.07% |
| 2000-03-31 | $33.97B | $2.52B | 7.42% |
| 1999-12-31 | $33.40B | $1.92B | 5.74% |
| 1999-09-30 | $31.72B | $6.71B | 21.16% |
| 1999-06-30 | $31.79B | $6.54B | 20.56% |
| 1999-03-31 | $32.99B | $6.76B | 20.48% |
| 1998-12-31 | $33.89B | $6.58B | 19.40% |
| 1998-09-30 | $37.85B | $2.42B | 6.38% |
| 1998-06-30 | $38.92B | $2.91B | 7.46% |
| 1998-03-31 | $39.01B | $2.78B | 7.14% |
| 1997-12-31 | $39.13B | $2.92B | 7.46% |
| 1997-09-30 | $39.39B | $1.02B | 2.59% |
| 1997-06-30 | $39.63B | $0.39B | 0.98% |
| 1997-03-31 | $40.14B | $-0.27B | -0.67% |
| 1996-12-31 | $40.97B | $-0.32B | -0.79% |
| 1996-06-30 | $28.53B | $0.90B | 3.15% |
| 1996-03-31 | $28.47B | $1.54B | 5.40% |
| 1995-09-30 | $38.67B | $1.70B | 4.40% |
| 1995-06-30 | $37.11B | $1.66B | 4.48% |
| 1995-03-31 | $35.48B | $1.51B | 4.25% |
| 1994-12-31 | $33.79B | $1.19B | 3.53% |
| 1994-06-30 | $22.52B | $0.70B | 3.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $30.091B | $20.173B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |